tiprankstipranks
Corcept Therapeutics (CORT)
NASDAQ:CORT
US Market
CORT
Corcept Therapeutics
RESEARCH TOOLSreports
Want to see CORT full AI Analyst Report?

Corcept Therapeutics (CORT) Stock News & Sentiment

1,303 Followers
Corcept stockholders approve expanded incentive plan and board
Premium
Company Announcements
Corcept stockholders approve expanded incentive plan and board
2d ago
8K
CORT
Corcept Therapeutics Signals Big Growth After Key Wins
Premium
Company Announcements
Corcept Therapeutics Signals Big Growth After Key Wins
26d ago
CORT
Corcept Therapeutics Guides Higher on Lifyorli-Fueled Revenue Growth
Premium
Company Announcements
Corcept Therapeutics Guides Higher on Lifyorli-Fueled Revenue Growth
30d ago
8K
CORT
Analyst Reiterates Buy on Corcept, Sees Upside with Unchanged $110 Target as Korlym Growth Set to Re-Accelerate and Lifyorli Ramps
Premium
Ratings
Analyst Reiterates Buy on Corcept, Sees Upside with Unchanged $110 Target as Korlym Growth Set to Re-Accelerate and Lifyorli Ramps
1M ago
CORT
Is CORT a Buy, Before Earnings?
Premium
Pre-Earnings
Is CORT a Buy, Before Earnings?
1M ago
CORT
Shareholders Sue Corcept Therapeutics Over Cushing’s Syndrome Drug Claims
Premium
Market News
Shareholders Sue Corcept Therapeutics Over Cushing’s Syndrome Drug Claims
2M ago
CORT
Corcept Faces Investor Suit Over Relacorilant NDA Disclosure 
Premium
Class Action
Corcept Faces Investor Suit Over Relacorilant NDA Disclosure 
2M ago
CORT
More CORT News >

CORT News on the Web

Top Corcept Executive Makes Notable Move With Fresh Stock Sale
TipRanks News
Bullish
Corcept stockholders approve expanded incentive plan and board
TipRanks News
Bullish
Corcept Therapeutics price target raised to $135 from $110 at Canaccord
TipRanks News
Bullish
Corcept Therapeutics price target raised to $95 from $75 at H.C. Wainwright
TipRanks News
Bullish
Corcept Therapeutics Jumps on Fresh FDA Milestone
TipRanks News
Bullish
Corcept's Relacorilant NDA Resubmission Targets FDA Review—Key Milestone for Cushing's Syndrome Patients
Market Chameleon
Neutral
Corcept Therapeutics to resubmit NDA to U.S. FDA for relacorilant
TipRanks News
Bullish
Why Corcept Therapeutics Stock Is Surging Now
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
CORT
Sector Average
Media Buzz
This Week7 articles
Weekly Average8.5 articles
News Sentiment
This Week99%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CORT’s Media Buzz Sentiment?
7 articles about CORT were published this week. In an average week, 8.5 articles are published.
    What is CORT’s weekly average amount of articles?
    In an average week, 8.5 articles about CORT are published.
      What is CORT’s News Sentiment?
      99% of articles about CORT were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        AKTXAkari Therapeutics
        IMMXImmix Biopharma
        SYSo-Young International
        ADOAnteoTech Ltd
        FSPKFFisher & Paykel Healthcare Corporation Limited
        Showing the stocks with the most bullish news sentiment over the past week